CANbridge Announces Marketing Approval of CAN108 (/LIVMARLI®) in Taiwan for the Treatment of Cholestatic Pruritus in Patients with Alagille Syndrome (ALGS) ...Middle East

LIVMARLI is the First and Only Treatment Approved in Taiwan for Cholestatic Pruritus in ALGS LIVMARLI is approved for Cholestatic Pruritus in ALGS in the US, Canada, Europe, Mainland China, and other regions globally BEIJING and BURLINGTON, Mass., Oct. 8, 2023 /PRNewswire/ -- CANbridge...

Hence then, the article about canbridge announces marketing approval of can108 livmarli in taiwan for the treatment of cholestatic pruritus in patients with alagille syndrome algs was published today ( Monday 09/10/2023 - 03:08 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( CANbridge Announces Marketing Approval of CAN108 (/LIVMARLI®) in Taiwan for the Treatment of Cholestatic Pruritus in Patients with Alagille Syndrome (ALGS) )

Also on site :

• Americans are feeling inflation’s pinch into the holiday weekend. Here’s where prices are rising the most
• Masculinity Satire Australian Animated Series ‘Finally, a Show About Men!’ Bows on YouTube (EXCLUSIVE)
• Amazon’s 'Very Soft' and 'Breathable' Matching Cotton Lounge Set Is Just $10, and It Comes in 15 Styles